Codes / ICD10CM / Z16.29

Z16.29 Resistance to other single specified antibiotic

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Resistance to other single specified antibiotic (ICD-10-CM Code: Z16.29)

Summary

Resistance to other single specified antibiotic is a condition where bacteria develop the ability to withstand the effects of a single, identified antibiotic not classified under broader resistance categories. This resistance can limit treatment options for infections, as the affected bacteria may no longer respond to the specific antibiotic.

Causes

The primary cause is genetic changes in bacteria that reduce the effectiveness of the specified antibiotic. These changes may include enzyme production that inactivates the drug, altered drug targets, or reduced drug uptake. Resistance can develop due to selective pressure from antibiotic use or horizontal gene transfer between bacteria.

Risk Factors

  • Previous or prolonged use of the specified antibiotic.
  • Hospitalization, particularly in intensive care units.
  • Weakened immune system from underlying conditions or treatments.
  • Presence of invasive medical devices (e.g., catheters, ventilators).
  • Exposure to healthcare environments with high resistance rates.

Symptoms

Resistance itself does not cause symptoms, but infections with resistant bacteria may present typical infection signs such as fever, pain, swelling, or discharge at the infection site, depending on the affected area.

Diagnosis

Diagnosis involves laboratory testing, such as culture and sensitivity tests, to identify resistance to the specified antibiotic. Molecular methods may also be used to detect resistant genes.

Treatment Options

Treatment depends on the specific antibiotic and infection type. Alternatives may include other antibiotics with activity against the resistant bacteria, guided by susceptibility testing. In some cases, combination therapy or higher doses may be considered.

Prognosis and Follow-Up

Prognosis varies based on the infection severity, the antibiotic involved, and the patient’s overall health. Close monitoring and follow-up are essential to ensure effective treatment and prevent recurrence. Resistance may complicate recovery, especially in immunocompromised individuals.

Complications

Complications can include treatment failure, prolonged illness, increased risk of spread to others, and the need for more aggressive or toxic therapies. In severe cases, resistant infections may lead to sepsis or organ damage.

Lifestyle & Prevention

  • Use antibiotics only as prescribed and complete the full course.
  • Practice good hygiene, such as handwashing, to reduce infection risk.
  • Avoid sharing antibiotics or using leftover medications.
  • Stay up-to-date with vaccinations to prevent infections.

When to Seek Professional Help

Seek medical attention if infection symptoms worsen or persist despite treatment, or if new symptoms (e.g., high fever, severe pain) develop. Early evaluation is crucial for resistant infections.

Tips for Medical Coders

Document the specific antibiotic to which resistance is identified. Ensure the code Z16.29 is used only when a single, specified antibiotic is documented. Verify that the resistance is not covered by a more specific code (e.g., vancomycin resistance).

Book a walkthrough

Z16.29 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.